This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% year over year, according to the newly published IMV 2024 PET Market Summary Report. In 2023, the average number of PETscans per fixed PET site (versus mobile PET) increased 6.7%
Zelefsky brings an unparalleled level of expertise and leadership that will further elevate our team at Perlmutter Cancer Center,” said Alec Kimmelman, MD, PhD , the Anita Steckler and Joseph Steckler Chair of the Department of RadiationOncology. milla1cf Tue, 09/12/2023 - 13:16 September 12, 2023 — Michael J.
Team members from the theranostics clinic under University of Texas Health Science Center at San Antonio's Department of Radiology show one aspect of a Pluvicto infusion treatment. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
Team members from the theranostics clinic under University of Texas Health Science Center at San Antonio's Department of Radiology show one aspect of a Pluvicto infusion treatment. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
This year, hundreds of candidates have been selected as semifinalists for 14 categories, ranging from Most Influential Radiology Researcher to Best New Radiology Software. The semifinalist list was compiled based on nominations from members of AuntMinnie.com. Winners will be selected by our expert panel in two rounds of voting.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content